VANGUARD GROUP INC - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 90 filers reported holding RELMADA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.59 and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,930,105
+22.0%
1,310,0350.0%0.00%
Q2 2023$3,222,686
-5.3%
1,310,035
-13.0%
0.00%
Q1 2023$3,401,253
-35.8%
1,504,979
-0.8%
0.00%
Q4 2022$5,294,260
-90.1%
1,516,980
+5.1%
0.00%
-100.0%
Q3 2022$53,456,000
+97.8%
1,443,960
+1.5%
0.00%
+100.0%
Q2 2022$27,023,000
-24.4%
1,423,032
+7.5%
0.00%0.0%
Q1 2022$35,736,000
+29.5%
1,324,014
+8.1%
0.00%0.0%
Q4 2021$27,598,000
+15.1%
1,224,901
+33.9%
0.00%0.0%
Q3 2021$23,975,000
-3.0%
914,723
+18.5%
0.00%0.0%
Q2 2021$24,705,000
+1.2%
771,776
+11.3%
0.00%0.0%
Q1 2021$24,411,000
+14.9%
693,307
+4.6%
0.00%0.0%
Q4 2020$21,250,000
-16.0%
662,623
-1.5%
0.00%0.0%
Q3 2020$25,311,000
-18.2%
672,781
-2.7%
0.00%0.0%
Q2 2020$30,951,000
+56.5%
691,652
+19.3%
0.00%0.0%
Q1 2020$19,779,000
-11.0%
579,858
+1.8%
0.00%0.0%
Q4 2019$22,220,000569,7530.00%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Guild Investment Management, Inc. 205,300$615,9001.03%
Deep Track Capital, LP 2,837,818$8,513,4540.33%
PARSONS CAPITAL MANAGEMENT INC/RI 974,082$2,922,2460.23%
apricus wealth, LLC 77,362$239,8220.21%
Palo Alto Investors LP 732,400$2,197,2000.21%
RTW INVESTMENTS, LP 2,131,835$6,395,5050.14%
SILVERARC CAPITAL MANAGEMENT, LLC 100,000$300,0000.09%
AdvisorShares Investments LLC 112,908$338,7240.09%
Savior LLC 3,500$10,5000.07%
Spotlight Asset Group, Inc. 20,000$60,0000.05%
View complete list of RELMADA THERAPEUTICS INC shareholders